| Amgen (AMGN) |
United States |
$167.609B |
16.77 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$120.955B |
31.12 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$115.809B |
28.32 |
| CSL (CSLLY) |
Australia |
$95.201B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$85.478B |
17.02 |
| Bristol Myers Squibb (BMY) |
United States |
$84.185B |
39.55 |
| GSK (GSK) |
United Kingdom |
$79.791B |
9.53 |
| Moderna (MRNA) |
United States |
$45.510B |
0.00 |
| Biogen (BIIB) |
United States |
$33.752B |
15.45 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$30.738B |
0.00 |
| Argenex SE (ARGX) |
Netherlands |
$25.558B |
0.00 |
| BioNTech SE (BNTX) |
Germany |
$19.104B |
160.72 |
| Illumina (ILMN) |
United States |
$16.628B |
118.61 |
| Genmab (GMAB) |
Denmark |
$16.618B |
19.48 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$15.633B |
60.99 |
| Sarepta Therapeutics (SRPT) |
United States |
$14.935B |
1316.67 |
| BeiGene (BGNE) |
Cayman Islands |
$13.671B |
0.00 |
| Incyte (INCY) |
United States |
$13.612B |
21.05 |
| Bio-Techne Corp (TECH) |
United States |
$11.291B |
42.65 |
| Insmed (INSM) |
United States |
$9.957B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$9.377B |
20.03 |
| Vaxcyte (PCVX) |
United States |
$8.215B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$8.085B |
26.44 |
| Legend Biotech (LEGN) |
United States |
$8.073B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$7.942B |
0.00 |
| Roivant Sciences (ROIV) |
United Kingdom |
$7.808B |
0.00 |
| Exact Sciences (EXAS) |
United States |
$7.796B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$7.231B |
0.00 |
| Repligen (RGEN) |
United States |
$7.044B |
92.01 |
| Exelixis (EXEL) |
United States |
$6.813B |
35.11 |
| Blueprint Medicines (BPMC) |
United States |
$6.749B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$6.664B |
18.50 |
| Zealand Pharma (ZLDPF) |
Denmark |
$6.663B |
0.00 |
| Viking Therapeutics (VKTX) |
United States |
$5.845B |
0.00 |
| Cytokinetics (CYTK) |
United States |
$5.681B |
0.00 |
| Krystal Biotech (KRYS) |
United States |
$5.244B |
0.00 |
| Nuvalent (NUVL) |
United States |
$4.897B |
0.00 |
| Apellis Pharmaceuticals (APLS) |
United States |
$4.656B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$4.586B |
0.00 |
| ImmunityBio (IBRX) |
United States |
$4.371B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$4.078B |
15.96 |
| Avidity Biosciences (RNA) |
United States |
$3.907B |
0.00 |
| Immunovant (IMVT) |
United States |
$3.859B |
0.00 |
| Axsome Therapeutics (AXSM) |
United States |
$3.823B |
0.00 |
| Guardant Health (GH) |
United States |
$3.534B |
0.00 |
| Merus (MRUS) |
Netherlands |
$3.473B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$3.417B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$3.311B |
0.00 |
| Biohaven (BHVN) |
United States |
$3.065B |
0.00 |
| HUTCHMED (China) (HCM) |
Hong Kong, SAR China |
$2.983B |
0.00 |
| Arcellx (ACLX) |
United States |
$2.953B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$2.943B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$2.938B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$2.869B |
0.00 |
| MoonLake Immunotherapeutics (MLTX) |
Switzerland |
$2.809B |
0.00 |
| SpringWorks Therapeutics (SWTX) |
United States |
$2.791B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$2.741B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$2.685B |
0.00 |
| IDEAYA Biosciences (IDYA) |
United States |
$2.657B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$2.592B |
101.64 |
| Geron (GERN) |
United States |
$2.515B |
0.00 |
| Rhythm Pharmaceuticals (RYTM) |
United States |
$2.504B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$2.439B |
0.00 |
| Apogee Therapeutics (APGE) |
United States |
$2.300B |
0.00 |
| Iovance Biotherapeutics (IOVA) |
United States |
$2.244B |
0.00 |
| Vericel (VCEL) |
United States |
$2.230B |
0.00 |
| Certara (CERT) |
United States |
$2.228B |
51.30 |
| Myriad Genetics (MYGN) |
United States |
$2.214B |
0.00 |
| Janux Therapeutics (JANX) |
United States |
$2.172B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$2.159B |
0.00 |
| CG Oncology (CGON) |
United States |
$2.104B |
0.00 |
| Fortrea Holdings (FTRE) |
United States |
$2.087B |
25.65 |
| Protagonist Therapeutics (PTGX) |
United States |
$2.032B |
14.20 |
| Vera Therapeutics (VERA) |
United States |
$1.979B |
0.00 |
| Rocket Pharmaceuticals (RCKT) |
United States |
$1.955B |
0.00 |
| Bavarian Nordic (BVNRY) |
Denmark |
$1.936B |
8.43 |
| Beam Therapeutics (BEAM) |
United States |
$1.929B |
0.00 |
| Kymera Therapeutics (KYMR) |
United States |
$1.832B |
0.00 |
| Structure Therapeutics (GPCR) |
United States |
$1.831B |
0.00 |
| Arvinas (ARVN) |
United States |
$1.822B |
0.00 |
| Novavax (NVAX) |
United States |
$1.778B |
0.00 |
| NeoGenomics (NEO) |
United States |
$1.771B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$1.745B |
0.00 |
| Zai Lab (ZLAB) |
China |
$1.719B |
0.00 |
| Harmony Biosciences Holdings (HRMY) |
United States |
$1.713B |
13.06 |
| Morphic Holding (MORF) |
United States |
$1.707B |
0.00 |
| Immunocore Holdings (IMCR) |
United Kingdom |
$1.695B |
0.00 |
| Edgewise Therapeutics (EWTX) |
United States |
$1.682B |
0.00 |
| Keros Therapeutics (KROS) |
United States |
$1.649B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$1.633B |
0.00 |
| Akero Therapeutics (AKRO) |
United States |
$1.622B |
0.00 |
| Mirum Pharmaceuticals (MIRM) |
United States |
$1.611B |
0.00 |
| Kura Oncology (KURA) |
United States |
$1.569B |
0.00 |
| Neumora Therapeutics (NMRA) |
United States |
$1.568B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$1.517B |
24.78 |
| Dynavax Technologies (DVAX) |
United States |
$1.470B |
187.17 |
| MannKind (MNKD) |
United States |
$1.421B |
174.00 |
| Arcus Biosciences (RCUS) |
United States |
$1.385B |
0.00 |
| Belite Bio (BLTE) |
United States |
$1.361B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$1.336B |
16.58 |
| Kiniksa Pharmaceuticals (KNSA) |
Bermuda |
$1.324B |
0.00 |
| Vir Biotechnology (VIR) |
United States |
$1.211B |
0.00 |
| Sana Biotechnology (SANA) |
United States |
$1.209B |
0.00 |
| Day One Biopharmaceuticals (DAWN) |
United States |
$1.204B |
0.00 |
| Verona Pharma American Depositary Share (VRNA) |
United Kingdom |
$1.169B |
0.00 |
| Disc Medicine (IRON) |
United States |
$1.114B |
0.00 |
| Prothena (PRTA) |
Ireland |
$1.110B |
0.00 |
| Arcutis Biotherapeutics (ARQT) |
United States |
$1.077B |
0.00 |
| Longboard Pharmaceuticals (LBPH) |
United States |
$1.051B |
0.00 |
| Tarsus Pharmaceuticals (TARS) |
United States |
$1.027B |
0.00 |
| Nurix Therapeutics (NRIX) |
United States |
$1.026B |
0.00 |
| MiMedx (MDXG) |
United States |
$1.023B |
43.31 |
| Gyre Therapeutics (GYRE) |
United States |
$1.020B |
0.00 |
| Cullinan Therapeutics (CGEM) |
United States |
$1.005B |
0.00 |
| Immatics (IMTX) |
Germany |
$0.984B |
0.00 |
| Spyre Therapeutics (SYRE) |
United States |
$0.947B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.926B |
0.00 |
| Tango Therapeutics (TNGX) |
United States |
$0.917B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.916B |
0.00 |
| AbCellera Biologics (ABCL) |
Canada |
$0.870B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.866B |
0.00 |
| Tyra Biosciences (TYRA) |
United States |
$0.840B |
0.00 |
| Abivax SA (ABVX) |
France |
$0.832B |
0.00 |
| Viridian Therapeutics (VRDN) |
United States |
$0.830B |
0.00 |
| Rapport Therapeutics (RAPP) |
|
$0.823B |
0.00 |
| Cogent Biosciences (COGT) |
United States |
$0.806B |
0.00 |
| 89BIO (ETNB) |
United States |
$0.788B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.778B |
0.00 |
| CureVac (CVAC) |
Germany |
$0.761B |
0.00 |
| Dianthus Therapeutics (DNTH) |
United States |
$0.760B |
0.00 |
| Ginkgo Bioworks Holdings (DNA) |
United States |
$0.739B |
0.00 |
| Cytek Biosciences (CTKB) |
United States |
$0.733B |
0.00 |
| Immunome (IMNM) |
United States |
$0.726B |
0.00 |
| Nuvation Bio (NUVB) |
United States |
$0.722B |
0.00 |
| HilleVax (HLVX) |
United States |
$0.719B |
0.00 |
| Praxis Precision Medicines (PRAX) |
United States |
$0.708B |
0.00 |
| Stoke Therapeutics (STOK) |
United States |
$0.704B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.685B |
0.00 |
| PureTech Health (PRTC) |
United States |
$0.677B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$0.664B |
0.00 |
| Arcturus Therapeutics Holdings (ARCT) |
United States |
$0.656B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$0.649B |
0.00 |
| CARGO Therapeutics (CRGX) |
United States |
$0.647B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.645B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$0.626B |
0.00 |
| ArriVent BioPharma (AVBP) |
United States |
$0.621B |
0.00 |
| Prime Medicine (PRME) |
United States |
$0.617B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.611B |
0.00 |
| GH Research (GHRS) |
Ireland |
$0.607B |
0.00 |
| Olema Pharmaceuticals (OLMA) |
United States |
$0.605B |
0.00 |
| Phathom Pharmaceuticals (PHAT) |
United States |
$0.603B |
0.00 |
| Zymeworks (ZYME) |
United States |
$0.602B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$0.601B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.583B |
0.00 |
| Mineralys Therapeutics (MLYS) |
United States |
$0.581B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$0.576B |
0.00 |
| Celcuity (CELC) |
United States |
$0.575B |
0.00 |
| Humacyte (HUMA) |
United States |
$0.572B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.571B |
0.00 |
| Pharming Group (PHAR) |
Netherlands |
$0.562B |
0.00 |
| Replimune (REPL) |
United States |
$0.553B |
0.00 |
| ITeos Therapeutics (ITOS) |
United States |
$0.536B |
0.00 |
| Applied Therapeutics (APLT) |
United States |
$0.534B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$0.533B |
0.00 |
| Third Harmonic Bio (THRD) |
United States |
$0.532B |
0.00 |
| Y-mAbs Therapeutics (YMAB) |
United States |
$0.530B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.526B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$0.525B |
0.00 |
| PepGen (PEPG) |
United States |
$0.517B |
0.00 |
| Mind Medicine (MindMed) (MNMD) |
United States |
$0.507B |
0.00 |
| MEREO BIOPHARMA (MREO) |
United Kingdom |
$0.505B |
0.00 |
| Astria Therapeutics (ATXS) |
United States |
$0.500B |
0.00 |
| Allogene Therapeutics (ALLO) |
United States |
$0.487B |
0.00 |
| Oculis Holding AG (OCS) |
Switzerland |
$0.484B |
0.00 |
| Entrada Therapeutics (TRDA) |
United States |
$0.481B |
22.62 |
| Cartesian Therapeutics (RNAC) |
United States |
$0.481B |
0.00 |
| Oric Pharmaceuticals (ORIC) |
United States |
$0.477B |
0.00 |
| Neurogene (NGNE) |
United States |
$0.472B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.453B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.453B |
0.00 |
| Contineum Therapeutics (CTNM) |
United States |
$0.453B |
0.00 |
| Annexon (ANNX) |
United States |
$0.453B |
0.00 |
| Terns Pharmaceuticals (TERN) |
United States |
$0.440B |
0.00 |
| Alector (ALEC) |
United States |
$0.438B |
0.00 |
| ACELYRIN, INC (SLRN) |
United States |
$0.437B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.430B |
0.00 |
| EnGene Holdings (ENGN) |
United States |
$0.416B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.414B |
0.00 |
| MaxCyte (MXCT) |
United States |
$0.409B |
0.00 |
| Erasca (ERAS) |
United States |
$0.409B |
0.00 |
| IGM Biosciences (IGMS) |
United States |
$0.405B |
0.00 |
| Ocugen (OCGN) |
United States |
$0.399B |
0.00 |
| Precigen (PGEN) |
United States |
$0.399B |
0.00 |
| AC Immune (ACIU) |
Switzerland |
$0.395B |
0.00 |
| Urogen Pharma (URGN) |
United States |
$0.394B |
0.00 |
| Fulcrum Therapeutics (FULC) |
United States |
$0.385B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$0.384B |
0.00 |
| Aura Biosciences (AURA) |
United States |
$0.375B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$0.373B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.369B |
316.62 |
| Cabaletta Bio (CABA) |
United States |
$0.361B |
0.00 |
| Oxford BioMedica (OXBDF) |
United Kingdom |
$0.358B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$0.357B |
0.00 |
| Anavex Life Sciences (AVXL) |
United States |
$0.357B |
0.00 |
| Agenus (AGEN) |
United States |
$0.352B |
0.00 |
| Scilex Holding (SCLX) |
United States |
$0.350B |
0.00 |
| Absci (ABSI) |
United States |
$0.348B |
0.00 |
| Jasper Therapeutics (JSPR) |
United States |
$0.342B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.329B |
0.00 |
| Kyverna Therapeutics (KYTX) |
United States |
$0.323B |
0.00 |
| C4 Therapeutics (CCCC) |
United States |
$0.318B |
0.00 |
| ALX Oncology Holdings (ALXO) |
United States |
$0.314B |
0.00 |
| TScan Therapeutics (TCRX) |
United States |
$0.309B |
0.00 |
| Nautilus Biotechnology (NAUT) |
United States |
$0.293B |
0.00 |
| Nkarta (NKTX) |
United States |
$0.292B |
0.00 |
| Orchestra BioMed Holdings (OBIO) |
United States |
$0.292B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.291B |
0.00 |
| Zentalis Pharmaceuticals (ZNTL) |
United States |
$0.291B |
0.00 |
| Alto Neuroscience (ANRO) |
United States |
$0.287B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.285B |
21.57 |
| Poseida Therapeutics (PSTX) |
United States |
$0.283B |
0.00 |
| Amarin (AMRN) |
Ireland |
$0.283B |
0.00 |
| Atea Pharmaceuticals (AVIR) |
United States |
$0.279B |
0.00 |
| Inozyme Pharma (INZY) |
United States |
$0.276B |
0.00 |
| XOMA (XOMA) |
United States |
$0.276B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.271B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$0.268B |
0.00 |
| Molecular Partners AG (MOLN) |
Switzerland |
$0.265B |
0.00 |
| ADC Therapeutics SA (ADCT) |
Switzerland |
$0.262B |
0.00 |
| Renovaro (RENB) |
United States |
$0.258B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$0.246B |
0.00 |
| Tenaya Therapeutics (TNYA) |
United States |
$0.243B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.241B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.240B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.238B |
0.00 |
| Skye Bioscience (SKYE) |
United States |
$0.225B |
0.00 |
| Greenwich LifeSciences (GLSI) |
United States |
$0.222B |
0.00 |
| Codexis (CDXS) |
United States |
$0.219B |
0.00 |
| Solid Biosciences (SLDB) |
United States |
$0.218B |
0.00 |
| UniQure (QURE) |
Netherlands |
$0.218B |
0.00 |
| Q32 Bio (QTTB) |
United States |
$0.214B |
0.00 |
| Trevi Therapeutics (TRVI) |
United States |
$0.210B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$0.209B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.206B |
0.00 |
| Inhibrx Biosciences (INBX) |
|
$0.205B |
0.00 |
| Gossamer Bio (GOSS) |
United States |
$0.204B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$0.198B |
0.00 |
| 2seventy Bio (TSVT) |
United States |
$0.198B |
0.00 |
| 23andMe Holding (ME) |
United States |
$0.192B |
0.00 |
| Rani Therapeutics Holdings (RANI) |
United States |
$0.192B |
0.00 |
| Design Therapeutics (DSGN) |
United States |
$0.189B |
0.00 |
| Monte Rosa Therapeutics (GLUE) |
United States |
$0.189B |
0.00 |
| Candel Therapeutics (CADL) |
United States |
$0.184B |
0.00 |
| Shattuck Labs (STTK) |
United States |
$0.184B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.180B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.177B |
0.00 |
| INmune Bio (INMB) |
United States |
$0.174B |
0.00 |
| Adocia (ADOCY) |
France |
$0.174B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.174B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.173B |
0.00 |
| Rezolute (RZLT) |
United States |
$0.173B |
0.00 |
| FibroBiologics (FBLG) |
United States |
$0.163B |
0.00 |
| Ventyx Biosciences (VTYX) |
United States |
$0.163B |
0.00 |
| Biomea Fusion (BMEA) |
United States |
$0.162B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.157B |
9.88 |
| Inventiva S.A (IVA) |
France |
$0.157B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.157B |
0.00 |
| ScPharmaceuticals (SCPH) |
United States |
$0.157B |
0.00 |
| XBiotech (XBIT) |
United States |
$0.157B |
0.00 |
| Lifecore Biomedical (LFCR) |
United States |
$0.156B |
0.00 |
| Zura Bio (ZURA) |
United States |
$0.153B |
0.00 |
| Vigil Neuroscience (VIGL) |
United States |
$0.150B |
0.00 |
| Caribou Biosciences (CRBU) |
United States |
$0.148B |
0.00 |
| Elevation Oncology (ELEV) |
United States |
$0.148B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.146B |
0.00 |
| Acumen Pharmaceuticals (ABOS) |
United States |
$0.145B |
0.00 |
| BioStem Technologies (BSEM) |
|
$0.145B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.142B |
0.00 |
| Repare Therapeutics (RPTX) |
Canada |
$0.140B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.138B |
0.00 |
| Compass Therapeutics (CMPX) |
United States |
$0.138B |
0.00 |
| Adagene (ADAG) |
China |
$0.135B |
0.00 |
| I-Mab (IMAB) |
China |
$0.135B |
0.00 |
| ProQR Therapeutics (PRQR) |
Netherlands |
$0.135B |
0.00 |
| Invivyd (IVVD) |
United States |
$0.131B |
0.00 |
| Kodiak Sciences (KOD) |
United States |
$0.123B |
0.00 |
| Elutia (ELUT) |
United States |
$0.120B |
0.00 |
| Adlai Nortye (ANL) |
Cayman Islands |
$0.120B |
0.00 |
| Semper Paratus Acquisition (TVGN) |
United States |
$0.120B |
0.00 |
| G1 Therapeutics (GTHX) |
United States |
$0.119B |
0.00 |
| Nuvectis Pharma (NVCT) |
United States |
$0.116B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.116B |
0.00 |
| Akoya Biosciences (AKYA) |
United States |
$0.116B |
0.00 |
| Omega Therapeutics (OMGA) |
United States |
$0.114B |
0.00 |
| Corvus Pharmaceuticals (CRVS) |
United States |
$0.114B |
0.00 |
| Opthea (OPT) |
Australia |
$0.113B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.112B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.110B |
0.00 |
| Seer (SEER) |
United States |
$0.109B |
0.00 |
| ATyr Pharma (ATYR) |
United States |
$0.108B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$0.108B |
0.00 |
| PDS Biotechnology (PDSB) |
United States |
$0.107B |
0.00 |
| Rapt Therapeutics (RAPT) |
United States |
$0.106B |
0.00 |
| Werewolf Therapeutics (HOWL) |
United States |
$0.106B |
0.00 |
| CervoMed (CRVO) |
United States |
$0.106B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.104B |
0.00 |
| Sagimet Biosciences (SGMT) |
United States |
$0.104B |
0.00 |
| InflaRx (IFRX) |
Germany |
$0.102B |
0.00 |
| Athira Pharma (ATHA) |
United States |
$0.102B |
0.00 |
| Immunic (IMUX) |
United States |
$0.100B |
0.00 |
| Adicet Bio (ACET) |
United States |
$0.099B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.099B |
0.00 |
| BioHarvest Sciences (CNVCD) |
Canada |
$0.099B |
0.00 |
| X4 Pharmaceuticals (XFOR) |
United States |
$0.097B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.097B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.095B |
6.10 |
| Tiziana Life Sciences (TLSA) |
United Kingdom |
$0.095B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.094B |
0.00 |
| BeyondSpring (BYSI) |
United States |
$0.094B |
0.00 |
| Coya Therapeutics (COYA) |
United States |
$0.089B |
0.00 |
| Allakos (ALLK) |
United States |
$0.089B |
0.00 |
| Earth Science Tech (ETST) |
United States |
$0.086B |
0.00 |
| Boundless Bio (BOLD) |
United States |
$0.086B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.085B |
82.25 |
| Connect Biopharma Holdings (CNTB) |
United States |
$0.084B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.083B |
0.00 |
| Ikena Oncology (IKNA) |
United States |
$0.080B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.077B |
0.00 |
| IO Biotech (IOBT) |
Denmark |
$0.077B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.077B |
0.00 |
| Oncolytics Biotech (ONCY) |
Canada |
$0.076B |
0.00 |
| Verastem (VSTM) |
United States |
$0.075B |
0.00 |
| Kronos Bio (KRON) |
United States |
$0.075B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$0.074B |
0.00 |
| China Health Industries Holdings (CHHE) |
China |
$0.074B |
0.00 |
| Anebulo Pharmaceuticals (ANEB) |
United States |
$0.071B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.071B |
0.00 |
| MediciNova (MNOV) |
United States |
$0.071B |
0.00 |
| Eupraxia Pharmaceuticals (EPRX) |
Canada |
$0.070B |
0.00 |
| Milestone Pharmaceuticals (MIST) |
Canada |
$0.070B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.070B |
2.55 |
| Galena Biopharma (SLS) |
United States |
$0.069B |
0.00 |
| Vor Biopharma (VOR) |
|
$0.068B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.067B |
0.00 |
| Intensity Therapeutics (INTS) |
United States |
$0.067B |
0.00 |
| Gritstone Bio (GRTS) |
United States |
$0.067B |
0.00 |
| Genelux (GNLX) |
United States |
$0.067B |
0.00 |
| Instil Bio (TIL) |
United States |
$0.067B |
0.00 |
| Cognition Therapeutics (CGTX) |
United States |
$0.067B |
0.00 |
| BioAtla (BCAB) |
United States |
$0.066B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.066B |
0.00 |
| Eledon Pharmaceuticals (ELDN) |
United States |
$0.066B |
0.00 |
| Benitec Biopharma (BNTC) |
United States |
$0.065B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.064B |
0.00 |
| Annovis Bio (ANVS) |
United States |
$0.064B |
0.00 |
| AN2 Therapeutics (ANTX) |
United States |
$0.064B |
0.00 |
| LENZ Therapeutics (LENZ) |
United States |
$0.063B |
0.00 |
| Celularity (CELU) |
United States |
$0.061B |
0.00 |
| Turnstone Biologics (TSBX) |
United States |
$0.061B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.060B |
0.00 |
| LakeShore Biopharma (LSB) |
China |
$0.060B |
0.00 |
| Aileron Therapeutics (ALRN) |
United States |
$0.060B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.059B |
0.00 |
| CollPlant Biotechnologies (CLGN) |
Israel |
$0.057B |
0.00 |
| Genenta Science S.p.A (GNTA) |
Italy |
$0.056B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.056B |
0.00 |
| Alpha Teknova (TKNO) |
United States |
$0.056B |
0.00 |
| ARCA Biopharma (ABIO) |
United States |
$0.056B |
0.00 |
| Rallybio (RLYB) |
United States |
$0.056B |
0.00 |
| Barinthus Biotherapeutics (BRNS) |
United Kingdom |
$0.055B |
0.00 |
| Ovid Therapeutics (OVID) |
United States |
$0.055B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.054B |
0.00 |
| Prenetics Global (PRE) |
Hong Kong, SAR China |
$0.054B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.053B |
0.00 |
| Provectus Biopharmaceuticals (PVCT) |
United States |
$0.053B |
0.00 |
| Immix Biopharma (IMMX) |
United States |
$0.052B |
0.00 |
| Lantern Pharma (LTRN) |
United States |
$0.050B |
0.00 |
| Leap Therapeutics (LPTX) |
United States |
$0.050B |
0.00 |
| Passage Bio (PASG) |
United States |
$0.049B |
0.00 |
| BioXcel Therapeutics (BTAI) |
United States |
$0.048B |
0.00 |
| Aerovate Therapeutics (AVTE) |
United States |
$0.048B |
0.00 |
| Clene (CLNN) |
United States |
$0.046B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$0.045B |
0.00 |
| NextCure (NXTC) |
United States |
$0.044B |
0.00 |
| Regencell Bioscience Holdings (RGC) |
Hong Kong, SAR China |
$0.044B |
0.00 |
| Kezar Life Sciences (KZR) |
United States |
$0.044B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.043B |
0.00 |
| CalciMedica (CALC) |
United States |
$0.043B |
0.00 |
| Ocean Biomedical (OCEA) |
United States |
$0.042B |
0.00 |
| Elicio Therapeutics (ELTX) |
United States |
$0.042B |
0.00 |
| Atara Biotherapeutics (ATRA) |
United States |
$0.041B |
0.00 |
| Curis (CRIS) |
United States |
$0.041B |
0.00 |
| Ocuphire Pharma (OCUP) |
United States |
$0.040B |
0.00 |
| Estrella Immunopharma (ESLA) |
United States |
$0.038B |
0.00 |
| Immuneering (IMRX) |
United States |
$0.038B |
0.00 |
| IN8bio (INAB) |
United States |
$0.037B |
0.00 |
| Cyclo Therapeutics (CYTH) |
United States |
$0.036B |
0.00 |
| Aadi Bioscience (AADI) |
United States |
$0.036B |
0.00 |
| Lexaria Bioscience (LEXX) |
Canada |
$0.036B |
0.00 |
| Acurx Pharmaceuticals (ACXP) |
United States |
$0.036B |
0.00 |
| Xilio Therapeutics (XLO) |
United States |
$0.035B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.035B |
0.00 |
| OKYO Pharma (OKYO) |
|
$0.034B |
0.00 |
| Dare Bioscience (DARE) |
United States |
$0.034B |
0.00 |
| Achilles Therapeutics (ACHL) |
United Kingdom |
$0.033B |
0.00 |
| MiNK Therapeutics (INKT) |
United States |
$0.033B |
0.00 |
| Quince Therapeutics (QNCX) |
United States |
$0.032B |
0.00 |
| Eyenovia (EYEN) |
United States |
$0.032B |
0.00 |
| NKGen Biotech (NKGN) |
United States |
$0.032B |
0.00 |
| Pluri (PLUR) |
Israel |
$0.031B |
0.00 |
| Lisata Therapeutics (LSTA) |
United States |
$0.029B |
0.00 |
| SAB Biotherapeutics (SABS) |
United States |
$0.029B |
0.00 |
| Bolt Biotherapeutics (BOLT) |
United States |
$0.029B |
0.00 |
| Promis Neurosciences (PMN) |
Canada |
$0.028B |
0.00 |
| Carmell (CTCX) |
United States |
$0.028B |
0.00 |
| Aligos Therapeutics (ALGS) |
United States |
$0.027B |
0.00 |
| RenovoRx (RNXT) |
United States |
$0.027B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.027B |
0.00 |
| Femasys (FEMY) |
United States |
$0.025B |
0.00 |
| BioAffinity Technologies (BIAF) |
United States |
$0.025B |
0.00 |
| Beyond Air (XAIR) |
United States |
$0.025B |
0.00 |
| HCW Biologics (HCWB) |
United States |
$0.024B |
0.00 |
| Equillium (EQ) |
United States |
$0.024B |
0.00 |
| Vincerx Pharma (VINC) |
United States |
$0.024B |
0.00 |
| NeuroBo Pharmaceuticals (NRBO) |
United States |
$0.024B |
0.00 |
| Brainstorm Cell Therapeutics (BCLI) |
United States |
$0.024B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.024B |
0.00 |
| Biora Therapeutics (BIOR) |
United States |
$0.024B |
0.00 |
| CytoMed Therapeutics (GDTC) |
Singapore |
$0.023B |
0.00 |
| UNITY Biotechnology (UBX) |
United States |
$0.023B |
0.00 |
| Aprea Therapeutics (APRE) |
United States |
$0.022B |
0.00 |
| Akari Therapeutics (AKTX) |
United Kingdom |
$0.021B |
0.00 |
| Spruce Biosciences (SPRB) |
United States |
$0.021B |
0.00 |
| BRIACELL THERAP (BCTX) |
Canada |
$0.021B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.021B |
0.00 |
| KALA BIO (KALA) |
United States |
$0.020B |
0.00 |
| Forte Biosciences (FBRX) |
United States |
$0.020B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.019B |
0.00 |
| Apollomics (APLM) |
United States |
$0.019B |
0.00 |
| Lumos Pharma (LUMO) |
United States |
$0.019B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.018B |
0.00 |
| Aytu BioPharma (AYTU) |
United States |
$0.017B |
0.00 |
| Talis Biomedical (TLIS) |
United States |
$0.016B |
0.00 |
| Evaxion Biotech (EVAX) |
Denmark |
$0.016B |
0.00 |
| Sensei Biotherapeutics (SNSE) |
United States |
$0.016B |
0.00 |
| NeuroSense Therapeutics (NRSN) |
Israel |
$0.015B |
0.00 |
| Kintara Therapeutics (KTRA) |
United States |
$0.015B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.014B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.014B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.014B |
0.00 |
| Aptose Biosciences (APTO) |
Canada |
$0.014B |
0.00 |
| Biorestorative Therapies (BRTX) |
United States |
$0.014B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.013B |
0.00 |
| Galecto (GLTO) |
Denmark |
$0.013B |
0.00 |
| Monopar Therapeutics (MNPR) |
United States |
$0.013B |
0.00 |
| Senti Biosciences (SNTI) |
United States |
$0.013B |
0.00 |
| Cardio Diagnostics Holdings (CDIO) |
United States |
$0.012B |
0.00 |
| Elevai Labs (ELAB) |
United States |
$0.011B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.011B |
0.00 |
| Imunon (IMNN) |
United States |
$0.011B |
0.00 |
| Coeptis Therapeutics Holdings (COEP) |
United States |
$0.011B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.010B |
0.00 |
| Purple Biotech (PPBT) |
Israel |
$0.010B |
0.00 |
| Longeveron (LGVN) |
United States |
$0.010B |
0.00 |
| Chemomab Therapeutics (CMMB) |
Israel |
$0.010B |
0.00 |
| Eterna Therapeutics (ERNA) |
United States |
$0.010B |
0.00 |
| MIRA Pharmaceuticals (MIRA) |
United States |
$0.009B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.008B |
0.00 |
| ABVC BioPharma (ABVC) |
United States |
$0.008B |
0.00 |
| Moleculin Biotech (MBRX) |
United States |
$0.008B |
0.00 |
| AEterna Zentaris (AEZS) |
Canada |
$0.008B |
0.00 |
| Sunshine Biopharma (SBFM) |
United States |
$0.008B |
0.00 |
| Cadrenal Therapeutics (CVKD) |
United States |
$0.008B |
0.00 |
| GeoVax Labs (GOVX) |
United States |
$0.007B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.007B |
0.00 |
| NuCana (NCNA) |
United Kingdom |
$0.007B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.007B |
0.00 |
| Kineta (KA) |
United States |
$0.007B |
0.00 |
| Bionomics (BNOX) |
Australia |
$0.006B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.006B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.006B |
0.00 |
| Telesis Bio (TBIO) |
United States |
$0.006B |
0.00 |
| Mustang Bio (MBIO) |
United States |
$0.006B |
0.00 |
| Tenax Therapeutics (TENX) |
United States |
$0.006B |
0.00 |
| Hepion Pharmaceuticals (HEPA) |
United States |
$0.006B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.005B |
0.00 |
| Lixte Biotechnology Holdings (LIXT) |
United States |
$0.005B |
0.00 |
| Pasithea Therapeutics (KTTA) |
United States |
$0.005B |
0.00 |
| Avalon GloboCare (ALBT) |
United States |
$0.005B |
0.00 |
| Creative Medical Technology Holdings (CELZ) |
United States |
$0.005B |
0.00 |
| TFF Pharmaceuticals (TFFP) |
United States |
$0.005B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.005B |
0.00 |
| Synaptogenix (SNPX) |
United States |
$0.005B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.005B |
0.00 |
| Adial Pharmaceuticals (ADIL) |
United States |
$0.005B |
0.00 |
| Hoth Therapeutics (HOTH) |
United States |
$0.005B |
0.00 |
| Enveric Biosciences (ENVB) |
United States |
$0.005B |
0.00 |
| Bright Minds Biosciences (DRUG) |
United States |
$0.005B |
0.00 |
| Biofrontera (BFRI) |
United States |
$0.005B |
0.00 |
| Artelo Biosciences (ARTL) |
United States |
$0.004B |
0.00 |
| Palisade Bio (PALI) |
United States |
$0.004B |
0.00 |
| Virios Therapeutics (VIRI) |
United States |
$0.004B |
0.00 |
| TC BioPharm (Holdings) (TCBP) |
United Kingdom |
$0.004B |
0.00 |
| Atrinsic (PTIX) |
United States |
$0.004B |
0.00 |
| GT Biopharma (GTBP) |
United States |
$0.004B |
0.00 |
| Trevena (TRVN) |
United States |
$0.004B |
0.00 |
| GENPREX (GNPX) |
United States |
$0.004B |
0.00 |
| Ensysce Biosciences (ENSC) |
United States |
$0.004B |
0.00 |
| NexImmune (NEXI) |
United States |
$0.004B |
0.00 |
| Portage Biotech (PRTG) |
|
$0.004B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.004B |
0.00 |
| Onconetix (ONCO) |
United States |
$0.004B |
0.00 |
| Lipella Pharmaceuticals (LIPO) |
United States |
$0.003B |
0.00 |
| Invo BioScience (INVO) |
United States |
$0.003B |
0.00 |
| ZyVersa Therapeutics (ZVSA) |
United States |
$0.003B |
0.00 |
| Revelation Biosciences (REVB) |
United States |
$0.003B |
0.00 |
| Entero Therapeutics (ENTO) |
United States |
$0.003B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.003B |
0.00 |
| Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.003B |
0.00 |
| Alzamend Neuro (ALZN) |
United States |
$0.003B |
0.00 |
| Silo Pharma (SILO) |
United States |
$0.003B |
0.00 |
| Tharimmune (THAR) |
United States |
$0.003B |
0.00 |
| Exicure (XCUR) |
United States |
$0.003B |
0.00 |
| Psyence Biomedical (PBM) |
United States |
$0.003B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.003B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.002B |
0.00 |
| Cingulate (CING) |
United States |
$0.002B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.002B |
0.00 |
| Virax Biolabs Group (VRAX) |
United Kingdom |
$0.002B |
0.00 |
| 180 Life Sciences (ATNF) |
United States |
$0.002B |
0.00 |
| NeuBase Therapeutics (NBSE) |
United States |
$0.001B |
0.00 |
| Notable Labs (NTBL) |
United States |
$0.001B |
0.00 |
| EFFECTOR Therapeutics (EFTR) |
United States |
$0.001B |
0.00 |
| Bone Biologics (BBLG) |
United States |
$0.001B |
0.00 |
| Seelos Therapeutics (SEEL) |
United States |
$0.001B |
0.00 |
| Scinai Immunotherapeutics (SCNI) |
Israel |
$0.001B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.001B |
0.00 |
| Biodexa Pharmaceuticals (BDRX) |
United Kingdom |
$0.001B |
0.00 |
| Virpax Pharmaceuticals (VRPX) |
United States |
$0.001B |
0.00 |
| Dermata Therapeutics (DRMA) |
United States |
$0.001B |
0.00 |
| Allarity Therapeutics (ALLR) |
United States |
$0.001B |
0.00 |
| CNS Pharmaceuticals (CNSP) |
United States |
$0.000B |
0.00 |
| GRI Bio (GRI) |
United States |
$0.000B |
0.00 |
| Aceragen (ACGN) |
United States |
$0.000B |
0.00 |
| Alvotech (ALVO) |
|
$0.000B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.000B |
0.00 |
| LAVA Therapeutics (LVTX) |
Netherlands |
$0.000B |
0.00 |
| Motif Bio Plc (MTFB) |
United Kingdom |
$0.000B |
0.00 |
| Mainz Biomed (MYNZ) |
Germany |
$0.000B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.000B |
0.00 |
| Pharvaris (PHVS) |
Netherlands |
$0.000B |
0.00 |
| VectivBio Holding AG (VECT) |
Switzerland |
$0.000B |
0.00 |
| Clovis Oncology (CLVSQ) |
United States |
$0.000B |
0.00 |
